Associate Professor, Internal Medicine, Ohio State University College of Medicine
Hematology
Dr. Craig C. Hofmeister, MD
|
|
Give Review
Craig C. Hofmeister, MD works in the field of Hematology. He researched medicine at The Ohio State University College of Medicine. He over the years received 6 awards: "CMS Meaningful Use Stage 1 Certification", "Business Firsts Forty Under 40 Award", "Early Career Achievement Award", "Imagine MMORE Award", "Internal Medicine Senior Resident of the Year Award" and "Samuel J. Roessler Research Scholarship". Craig C. Hofmeister is a published physician. He has 67 papers published. The most current publication "Wavelet analysis of SAECG to identify patients with conduction defects at risk for sudden cardiac death." He accepts Medicare.
Publications
- Proteomic characterization of circulating extraCellular vesicles identifies novel serum myeloma associated markers.
- Atorvastatin for the Prophylaxis of Acute Graft vs. Host Disease (GVHD) in Patients Undergoing HLA-Matched Related Donor Hematopoietic Stem Cell Transplantation (HSCT).
- Lower dose of antithymocyte globulin does not increase Graft-versus-host disease in patients undergoing reduced-intensity conditioning allogeneic hematopoietic stem ce...
- A phase 1 study of vorinostat maintenance after autologous transplant in high-risk Lymphoma.
- A Phase 1 Trial of Single Agent Reolysin in Patients with Relapsed Multiple Myeloma.
- The hematopoietic stem cell transplant comorbidity index can predict for 30-day readmission following autologous stem cell transplant for Lymphoma and multiple myeloma.
- Circulating miRNA markers show promise as new prognosticators for multiple Myeloma.
- Aprepitant for the control of delayed nausea and vomiting associated with the use of high-dose melphalan for autologous peripheral blood stem Cell transplants in patie...
- Genetic Modification of T Cells Redirected towards CS1 Enhances Eradication of Myeloma Cells.
- Novel gelsolin variant as the cause of nephrotic Syndrome and renal amyloidosis in a large kindred.
- Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple Myeloma: a randomized phase 2 study.
- Sensitive liquid chromatography/mass spectrometry methods for quantification of pomalidomide in mouse plasma and Brain tissue.
- FLT3L and Plerixafor Combination Increases Hematopoietic Stem Cell Mobilization and Leads to Improved Transplantation Outcome.
- Elotuzumab directly enhances NK Cell cytotoxicity against myeloma via CS1 ligation: evidence for augmented NK Cell function complementing ADCC.
- A phase I trial of flavopiridol in relapsed multiple Myeloma.
- CS1-specific chimeric antigen receptor (CAR)-engineered natural killer Cells enhance In Vitro and In Vivo anti-tumor activity against human multiple myeloma.
- Characterization of Multiple Myeloma Vesicles by Label-Free Relative Quantitation.
- MicroRNAs activate natural killer Cells through toll-like receptor signaling.
- Standard Pentostatin Dose Reductions in Renal Insufficiency Are Not Adequate: Selected Patients with Steroid-Refractory Acute Graft-Versus-Host Disease.
- In vivo NCL targeting affects breast Cancer aggressiveness through miRNA regulation.
- Phase I pilot study of oxaliplatin, infusional 5-FU, and cetuximab in recurrent or metastatic head and neck Cancer.
- Early versus delayed autologous stem Cell transplant in patients receiving novel therapies for multiple myeloma.
- A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple Myeloma.
- Chemotherapeutic Agents Increase the Risk for Pulmonary Function Test Abnormalities in Patients With Multiple Myeloma.
- Unique Pattern of Renal κ Light Chain Amyloid Deposition With Histiocytic Transdifferentiation of Tubular Epithelial Cells.
- Serum free light chains in Myeloma patients with an intact M protein by immunofixation: potential roles for response assessment and prognosis during induction therapy ...
- IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer Cell versus multiple myeloma effect.
- Phase I Trial of Lenalidomide and CCI-779 in Patients With Relapsed Multiple Myeloma: Evidence for Lenalidomide-CCI-779 Interaction via P-Glycoprotein.
- Lenalidomide, bortezomib, pegylated liposomal doxorubicin, and dexamethasone in newly diagnosed multiple Myeloma: a phase 1/2 Multiple Myeloma Research Consortium trial.
- The PD-1/PD-L1 axis modulates the natural killer Cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody.
- TTP Disease course is independent of myeloma treatment and response.
- The novel deacetylase inhibitor AR-42 demonstrates pre-clinical activity in B-Cell malignancies in vitro and in vivo.
- Allogeneic stem cell transplantation for patients with relapsed chemorefractory aggressive non-hodgkin Lymphomas.
- Development and validation of a highly sensitive liquid chromatography/mass spectrometry method for simultaneous quantification of lenalidomide and flavopiridol in hum...
- Addition of infliximab to standard Acute graft-versus-host disease prophylaxis following allogeneic peripheral blood cell transplantation.
- The effect of statin use at the time of autologous transplant on response and survival in multiple Myeloma.
- Clinical utility of autopsy after hematopoietic stem Cell transplantation.
- Mucosal protection by cytokines.
- Graft-versus-host disease of the skin: life and death on the epidermal edge.
- Conflicts of interest, authorship, and disclosures in industry-related scientific publications.
- Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic Cell transplantation following fludarabine, busulfan-based re...
- Phase I adjuvant radiation with docetaxel in high-risk head and neck Cancer.
- Improved nonrelapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced-intensity conditioning allogeneic transplanta...
- Effects of induction with novel agents versus conventional chemotherapy on mobilization and autologous stem Cell transplant outcomes in multiple myeloma.
- Initial genome sequencing and analysis of multiple Myeloma.
- Evaluation of pulmonary infiltrates in patients after stem Cell transplantation.
- Central Nervous system post-transplant lymphoproliferative disorder despite negative serum and spinal fluid Epstein-Barr virus DNA PCR.
- Phase II clinical trial of arsenic trioxide with liposomal doxorubicin, vincristine, and dexamethasone in newly diagnosed multiple Myeloma.
- Retrospective utility of bronchoscopy after hematopoietic stem Cell transplant.
- Ex vivo expansion of umbilical cord blood stem Cells for transplantation: growing knowledge from the hematopoietic niche.
- Size-based speciation of natural colloidal particles by flow field flow fractionation, inductively coupled plasma-mass spectroscopy, and transmission electron microsco...
- The development of communicative competence of securely and insecurely attached children in interactions with their mothers.
- Cigarette smoking as a determinant of high-grade carotid artery stenosis in Hispanic, black, and white patients with stroke or transient ischemic attack.
- Wavelet analysis of SAECG to identify patients with conduction defects at risk for sudden cardiac death.
- Prospective study on the complication rate of carotid surgery.
- Placebo controlled pilot trial to study the remyelinating potential of intravenous immunoglobulins in multiple sclerosis.
- Interrater agreement for high grade carotid artery stenosis measurement and treatment decision.
- Predictive value of clinical lacunar Syndromes for lacunar infarcts on magnetic resonance brain imaging.
- Demographic, morphological, and clinical characteristics of 1289 patients with Brain arteriovenous malformation.
- Determinants of neurological outcome after surgery for Brain arteriovenous malformation.
- Scattered brain infarct pattern on diffusion-weighted magnetic resonance imaging in patients with Acute ischemic stroke.
- Phase II evaluation of paclitaxel in combination with carboplatin in advanced head and neck Carcinoma.
- Effect of age on clinical and morphological characteristics in patients with Brain arteriovenous malformation.
- Long-Term Therapy with Lenalidomide in a Patient with POEMS Syndrome.
- Granulocyte Colony-Stimulating Factor-Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host Disease.
- Phase 1 study of marizomib in relapsed or relapsed and refractory multiple Myeloma; NPI 0052 101 Part 1.
Schools
Ohio State University College Of Medicine and Public Health
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- HPC Transplantation (Stem Cell Transplant)
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Business First’s Forty Under 40 Award
- Early Career Achievement Award
- Imagine MMORE Award
- Internal Medicine Senior Resident of the Year Award
- Samuel J. Roessler Research Scholarship
Education
-
Ohio State University -
Loyola University -
The Ohio State University College of Medicine -
Brown University
Hospital
-
Ohio State University Wexner Medical Center
Drug Facts
| NPI NUMBER | 1497785232 | |
| NPPES Provider LastName | HOFMEISTER | |
| NPPES Provider FirstName | CRAIG | |
| NPPES Provider ZIPCode | 432101280 | |
| NPPES Provider State | OH | |
| Specialty Description | Hematology | |
| Total Claim Count | 639.0 | |
| Distinct Opioid Count | 6.0 | |
| Opioid Claim Count | 180.0 | |
| Percent Opioid Claims | 28.17 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1497785232 |
| Last Name Of The Provider | HOFMEISTER |
| First Name Of The Provider | CRAIG |
| View All |
Similar Doctors
|
Dr. Neil C. Dunavin, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Ahmed M. Ghany, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter J. Kourlas, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. John C. Byrd, MD |
|
|
Dr. Scott C. Blair, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas S. Lin, MD |
|
Dr. Rachel M. Layman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Joseph M. Flynn, DO |
|
Dr. William G. Blum, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William L. Marsh Jr., MD |